In today’s globalised world, counterfeit pharmaceuticals have emerged as a silent epidemic, endangering the health and lives of millions. The…
Read MoreCategory: Information
Filter By
2023 Patent Landscape Report: COVID-19-related vaccines and therapeutics
Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus….
Read MoreUnravelling the mysteries of motor neurone disease
Motor Neurone Disease (MND) is a debilitating neurodegenerative disease that affects the brain and spinal cord, leading to the death…
Read MoreThe exponential rise in counterfeit goods
With an estimated 4.48 billion social media users worldwide, it is unsurprising that counterfeiters, and those promoting counterfeit goods, have…
Read MoreDo safety regulations inhibit innovation in the aerospace sector?
Reading this headline, you might think that safety inhibiting innovation isn’t a bad thing. Stockton Rush, founder of OceanGate® Expeditions…
Read MoreWho should own the IP in work generated by AI?
Since the launch of ChatGPT in November 2022, the power of AI has been at the forefront of many peoples’…
Read MoreUnder the influence? Protecting your brand on social media platforms
Influencer culture is prevalent across all social media platforms, offering a relatively new and powerful marketing channel for brands. It’s…
Read MoreEnergy giants advance investment to accelerate clean energy solutions
According to the IEA report ‘Emissions from Oil and Gas Operations in Net Zero Transitions’, oil and gas operations account…
Read MoreDrone sector patents take off as innovation accelerates
Unmanned Aerial Systems (UAS) is a rapidly growing sub-sector within the aerospace industry. UAS are formed of one or more…
Read MoreThe sky is the limit for aerospace IP
Historically, the aerospace sector has been a major player in the world of Intellectual Property (IP). While technology and consumer…
Read MoreFour steps to take the heat out of a cease-and-desist letter
It’s the correspondence that no one wants to receive: a cease-and-desist letter, informing the recipient that they are infringing Intellectual…
Read MoreWhy the EPO’s Enlarged Board of Appeal’s decision in G2/21 will impact inventions relating to life sciences and chemistry
The European Patent Office’s (EPO) Enlarged Board of Appeal’s decision in G2/21 primarily relates to when data that only becomes…
Read More